These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36067233)

  • 1. Laboratory evaluation of RealStar Yellow Fever Virus RT-PCR kit 1.0 for potential use in the global yellow fever laboratory network.
    Basile AJ; Niedrig M; Lambert AJ; Meurant R; Brault AC; Domingo C; Goodman CH; Johnson BW; Mossel EC; Mulders MN; Velez JO; Hughes HR
    PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010770. PubMed ID: 36067233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
    Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
    Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective.
    Mengesha Tsegaye M; Beyene B; Ayele W; Abebe A; Tareke I; Sall A; Yactayo S; Shibeshi ME; Staples E; Belay D; Lilay A; Alemu A; Alemu E; Kume A; H/Mariam A; Ronveaux O; Tefera M; Kassa W; Bekele Weyessa A; Jima D; Kebede A; Tayachew A
    BMC Public Health; 2018 Aug; 18(1):1011. PubMed ID: 30107830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow fever in the diagnostics laboratory.
    Domingo C; Charrel RN; Schmidt-Chanasit J; Zeller H; Reusken C
    Emerg Microbes Infect; 2018 Jul; 7(1):129. PubMed ID: 30002363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory capacity assessments in 25 African countries at high risk of yellow fever, August-December 2018.
    Johnson BW; Demanou M; Fall G; Betoulle JL; Obiekea C; Basile AJ; Domingo C; Goodman C; Mossel E; Reusken C; Staples E; de Morais JFM; Neto Z; Paixão P; Denon YE; Glitho M; Mahinou J; Kagone T; Nakoune E; Gamougam K; Simbu EP; Ahuka S; Mombouli JV; Goma-Nkoua C; Adjogoua EV; Tayachew A; Beyene B; Sanneh B; Jarju ML; Mendy A; Amelor DK; Ofosu-Appiah L; Opare D; Antwi L; Adade R; Magassouba N; Gomes SF; Limbaso S; Lutomiah J; Gbelee B; Dogba J; Cisse I; Idde Z; Ihekweazu C; Mba N; Faye O; Faye O; Sall AA; Koroma Z; Juma MA; Maror JA; Eldigail M; Elduma AH; Elageb R; Badziklou K; Komla KA; Kayiwa J; Lutwama JJ; Hampton L; Mulders MN
    Pan Afr Med J; 2021; 38():402. PubMed ID: 34381546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integrated approach to yellow fever surveillance: pilot study in Senegal in 2003-2004].
    Faye O; Diallo M; Dia I; Ba Y; Faye O; Mondo M; Sylla R; Faye PC; Sall AA
    Bull Soc Pathol Exot; 2007 Aug; 100(3):187-92. PubMed ID: 17824313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical viability of the YF MAC-HD ELISA kit for use in yellow fever-endemic regions.
    Goodman CH; Demanou M; Mulders M; Mendez-Rico J; Basile AJ
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009417. PubMed ID: 34086676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Risk and Elimination of Yellow Fever Epidemics.
    Ndeffo-Mbah ML; Pandey A
    J Infect Dis; 2020 Jun; 221(12):2026-2034. PubMed ID: 31545372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: investigation of transmission to vaccine recipients.
    Hussain AI; Johnson JA; Da Silva Freire M; Heneine W
    J Virol; 2003 Jan; 77(2):1105-11. PubMed ID: 12502826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, drivers and global health implications of the 2019/2020 yellow fever sporadic outbreaks in Sub-Saharan Africa.
    Uchenna Emeribe A; Nasir Abdullahi I; O R Ajagbe O; Egede Ugwu C; Oloche Onoja S; Dahiru Abubakar S; Modesta Umeozuru C; Sunday Animasaun O; Omoruyi Omosigho P; Mukhtar Danmusa U; Alhaji Baba Mallam M; Saidu Aminu M; Yahaya H; Oyewusi S
    Pathog Dis; 2021 Apr; 79(4):. PubMed ID: 33739369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Staples JE; Gershman M; Fischer M;
    MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Real-Time Reverse Transcription-PCR Assay for Global Differentiation of Yellow Fever Virus Vaccine-Related Adverse Events from Natural Infections.
    Hughes HR; Russell BJ; Mossel EC; Kayiwa J; Lutwama J; Lambert AJ
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29643198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sanger-based sequencing technology for yellow fever vaccine genetic quality control.
    Pestana CP; Lawson-Ferreira R; Lessa-Aquino C; Leal MDLF; Freire MDS; Homma A; Medeiros MA
    J Virol Methods; 2018 Oct; 260():82-87. PubMed ID: 30009851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources.
    Adrien N; Hyde TB; Gacic-Dobo M; Hombach J; Krishnaswamy A; Lambach P
    Vaccine; 2019 Jul; 37(32):4511-4517. PubMed ID: 31266670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-yellow fever virus detection and lineage assignment by real-time RT-PCR and amplicon sequencing.
    Faggioni G; De Santis R; Moramarco F; Di Donato M; De Domenico A; Molinari F; Petralito G; Fortuna C; Venturi G; Rezza G; Lista F
    J Virol Methods; 2023 Jun; 316():114717. PubMed ID: 36972832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological Protection 5-6 Years Post Vaccination Against Yellow Fever in African Infants Vaccinated in Routine Programmes.
    Idoko OT; Domingo C; Tapia MD; Sow SO; Geldmacher C; Saathoff E; Kampmann B
    Front Immunol; 2020; 11():577751. PubMed ID: 33133096
    [No Abstract]   [Full Text] [Related]  

  • 17. Yellow fever: the recurring plague.
    Tomori O
    Crit Rev Clin Lab Sci; 2004; 41(4):391-427. PubMed ID: 15487593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yellow fever risk assessment in the Central African Republic.
    Staples JE; Diallo M; Janusz KB; Manengu C; Lewis RF; Perea W; Yactayo S; Sall AA;
    Trans R Soc Trop Med Hyg; 2014 Oct; 108(10):608-15. PubMed ID: 24947520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an ELISA kit (YF MAC-HD) to detect IgM to yellow fever virus.
    Basile AJ; Goodman C; Horiuchi K; Laven J; Panella AJ; Kosoy O; Lanciotti RS; Johnson BW
    J Virol Methods; 2015 Dec; 225():41-8. PubMed ID: 26342907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response to re-emergence of yellow fever in Nigeria, 2017.
    Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
    Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.